House dust mite sublingual immunotherapy and rhinitis-related quality of life in biologic-controlled severe asthma: A propensity score–matched real-world study

Makoto Hoshino, Tatsuhiko Harada, Hiroshi Kitamura, Junichi Ootawa

Open source

DOI
10.1016/j.rmed.2026.109275
Published
2026-11
Container
Respiratory Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmed.2026.109275,
  title = {House dust mite sublingual immunotherapy and rhinitis-related quality of life in biologic-controlled severe asthma: A propensity score–matched real-world study},
  author = {Makoto Hoshino and Tatsuhiko Harada and Hiroshi Kitamura and Junichi Ootawa},
  year = {2026},
  journal = {Respiratory Medicine},
  doi = {10.1016/j.rmed.2026.109275},
  url = {https://doi.org/10.1016/j.rmed.2026.109275}
}

RIS

TY  - JOUR
TI  - House dust mite sublingual immunotherapy and rhinitis-related quality of life in biologic-controlled severe asthma: A propensity score–matched real-world study
AU  - Makoto Hoshino
AU  - Tatsuhiko Harada
AU  - Hiroshi Kitamura
AU  - Junichi Ootawa
PY  - 2026
JO  - Respiratory Medicine
DO  - 10.1016/j.rmed.2026.109275
UR  - https://doi.org/10.1016/j.rmed.2026.109275
ER  - 

APA

Hoshino, M., Harada, T., Kitamura, H., & Ootawa, J. (2026). House dust mite sublingual immunotherapy and rhinitis-related quality of life in biologic-controlled severe asthma: A propensity score–matched real-world study. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2026.109275

Source records